Waist circumference, waist to hip ratio, and body mass index in the diagnosis of metabolic syndrome in nigerian subjects

Nigerian Journal of Physiological Sciences

Volumn 25, Issue 2, 2010, Pages 187-195

  Ghazali, S M ^a   Sanusi, R A ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Anthropometric indices; Metabolic syndrome; Nigerian

Indexed keywords

BODY MASS; CROSS-SECTIONAL STUDY; HUMAN; METABOLIC SYNDROME X; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

BODY MASS INDEX; CROSS-SECTIONAL STUDIES; HUMANS; METABOLIC SYNDROME X; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84881239476     PISSN: 0794859X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Alberti KG, Zimmet PZ; Definition, diagnosis and classification of diabetes mellitus and itscomplications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
2. Ameen IO, Fawole O; Prevalence of Risk Factors for Cardiovascular Disease among Nigerian Youth.(unpublished report)
3. Bakari AG, Onyemelukwe GC, Sani BG, Aliyu IS, Hassan SS and Aliyu TM; Obesity, overweight andunderweight in suburban northern Nigeria; Int J Diabetes & Metabolism; 2007 (15): 68-69.
4. Balkau B, Charles MA: Comment on the provisional report from the WHO Consultation:European Group for the Study of Insulin Resistance (EGIR). Diabet Med16: 442-443, 1999
5. Bray GA, Bouchard C, James WPT. Definitions and proposed current classification of Obesity, In: BrayGA, Bouchard C, James WPT, eds. Handbook of obesity. New York: Marcel Dekker, Inc, 1998: 31-40
6. Body Measurements (Anthropometry); NHANES III (Oct, 1988), Westat, Inc. 1650 Research BoulevardRockville, MD 20850 (301): 251-1500.
7. Body Measurements (Anthropometry); NHANES III (Oct, 1988), Westat, Inc. 1650 Research BoulevardRockville, MD 20850 (301): 251-1500
8. Deen D. Metabolic Syndrome; Time for Action. Am Fam. Physician; 69 (12): June 2004, 2876-2882
9. Diabetes and Obesity: Time to Act. International Diabetes Federation (IDF) and InternationalAssociation for the Study of Obesity (IASO), 2004
10. Dobbelsteyn CJ, Joffres MR, MacLean DR, Flowerdew G and The Canadian Heart Health SurveysResearch Group; A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys; Int J of Obesity (2001) 25, 652-661
11. Duggleby SL, Jackson AA, Godfrey KM, Robinson SM, InskipHM;The Southampton Women's SurveyStudy Group; Cut-offpoints for anthropometric indices of adiposity: differential classification ina large population of young women. Br J. of Nutr 2008.
12. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS
13. Kendall D, Krauss RM, Neufeld ND, Petak SM, Rodbard HW, Seibel JA, Smith DA, Wilson PW: American College of Endocrinology position statement on the insulin resistance syndrome. EndocrPract9:237-252, 2003
14. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP)Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497
15. Fezeu L, Balkau B, Kengne AP, Sobngwi E, and Mbanya JC;Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant; Atherosclerosis.2007 July; 193(1): 70-76.
16. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G: Insulin resistance andhypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).J Clin Invest 100:1166-1173, 1997
17. Ford ES: Prevalence of the metabolic syndrome in US populations. EndocrinolMetabClinNorth Am33:333-350, 2004
18. Gadzik J: "How Much Should I Weigh?"-Quetelet's Equation, Upper Weight Limits andBMI Prime Connecticut Medicine, Feb 2006; 70: 81-88.
19. Genest J, Frohlich J, Fodor, et al. Recommendations for the management of dyslipidemia and theprevention of cardiovascular disease: summary of the 2003 update, CMAJ, Oct.28, 2003169 (9).
20. Golden SH, Folsom AR, Coresh J et al. Risk factor grouping related to insulin resistance andtheir synergistic effects on subclinical atherosclerosis: the atherosclerosis risk incommunities study. Diabetes 2002;51:3069-76.
21. Hu G, Qiao Q, Tuomilehto J et al for the DECODE Study Group. Prevalence of the metabolicsyndrome and its relation to all-cause and cardiovascular mortality in nondiabeticEuropean men and women. Arch Intern Med 2004; 164:1066-1076
22. Hill AM, LaForgia J, Coates AM, Buckley JD, Howe PRC; Estimating Abdominal AdiposeTissue with DXA and Anthropometry: Obesity; 15(2) 2007, 504-510
23. Haffner SM; Obesity and the metabolic syndrome: the San Antonio Heart Study; Br J. ofNutrition(2000), 83, Suppl. 1, S67-S70
24. International Diabetes Federation: The IDF consensus worldwide definition of the metabolicsyndrome. Available from http://www.idf.org/webdata/docs/Metabolic Syndromedefinition.pdf. Accessed 2 September 2005
25. JNC 6: The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluationand Treatment of High Blood Pressure. NIH Pub; 98-4080 (1997).
26. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D, Rabasa-Lhoret R: The metabolically healthy but obese individual presents a favorable inflammation profile. J ClinEndocrinolMetab90:4145-4150, 2005
27. Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue S. Criteria and Classification of obesity in Japan and Asia-Ocaenia: World Rev Nutr Diet. Basel, Karger, 2005, 94; 1-12
28. Kanjilal S, Shanker J, Rao VS, Khashinarashimhaih NB, Mukherjee M, Iyengar SS, Kskkar V. Prevalence and component analysis of metabolic syndrome: An Indian atherosclerosis research study perspective. Vascular Health and Risk Management 2008: 4(1) 189-197
29. Knowler WC, Barett-Conor E, Fowler SE, Haman RE, Lachin JM, Walker EA et al. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin N Engl J Med: 346 (6), 2002; 396-403
30. Kolasa KM. Summary of the JNC 7 Guidelines for the Prevention and Treatment of High Blood Pressure. J of NutrEduc and Behaviour; 35(5) 2003: 226-227
31. Li C, Ford ES, Mokdad AH and Stephen Cook;Recent Trends in Waist Circumference and Waist-Height Ratio Among US Children and Adolescents; PEDIATRICS Vol 118(5) Nov. 2006, pp e1390-e1398
32. Liu J, Grundy SM, Wang W, Smith SC, Vega GL, Zhaosuwu et al;The metabolic syndrome in Chinese. Diab Care; 29 (6), June 2006, 1414-1416
33. Meigs JB: Metabolic Syndrome: In search of a clinical role. Diabetes Care 27:2761-2763, 2004.
34. Muhammed EA, Muhammed M, Dennis L, Rekia B. Prevalence of Parameter Indicators of Obesity and its Relationship with Metabolic Syndrome in Urban Moroccan Women; Am J Hum Biol. 00:000-000 (2008) 1-3
35. National Institutes of Health. The practical guide-identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, MD: NIH, 2000. (NIH Publication no.00-4084.)
36. National Institute of Health..Aim for a Healthy Weight: Assess your Risk. National Institutes of Health. July, 2007
37. Nyenwe EA,, Odia OJ, Ihekwaba AE, Ojule A, BabatundeS. Type 2 Diabetes in adult Nigerians: a study of its prevalence and risk factors in Port Harcourt, Nigeria. Diabetes Research and Clinical Practice 62; 2003; 177-185.
38. O'Meara YM, Brady HR, Brenner BM; Glomerulopathies Associated with Multisyste Diseases. In; Denis L Klasper, Anthony S Fauci, Dan L Longo, Eugene Braunwald, StephenL Hauser, Larry Jameson (Eds) Harrison's Principles of Internal Medicine, 16th ed.
39. McGraw-Hill, Philadelphia; 2005;1590
40. Rankinen T, Zuberi A, Chagnon YC et al. The human obesity gene map: the 2005 update. Obesity; 2006 (14): 529-644.
41. Ravalgia G, Forti P, Maioli F, Bastagli L, et a. Metabolic Syndrome: Prevalence and prediction of mortality in elderly individuals. Diab Care (29) 2006; 2471-2476l
42. Ruderman NB, Schneider SH, Berchtold P: The "metabolically-obese," normal-weight individual. Am J ClinNutr34:1617-1621, 1981
43. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S: The metabolically obese, normal weight individual revisited. Diabetes 47:699-713, 1998
44. Ryan MC, Farin HMF, Abbasi F, Reaven GM. Comparison of Waist Circumference Versus Body Mass Index in Diagnosing Metabolic Syndrome and Identifying Apparently Healthy Subjects at Increased Risk of Cardiovascular Disease, The Am. J of Cardiol. 2008;102:40-46 (www. AJConline.org)
45. UKPDS Group. UK Prospective Diabetes Study 17: A nine-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996;124:136-458
46. Wallace TM, Mattews DR. The assessment of insulin resistance in man. Diabet Med 2002;19:527-34.
47. Wat NMS, Lam TH, Janus ED and Lam KSL; Central obesity predicts the worsening of glycemia in southern Chinese. International Journal of Obesity (2001) 25, 1789-1793
48. Wannamethee SG, Sharper AG, Morris RW, Whincorp PH. Measures of adiposity in the identification of metabolic abnormalties in elderly men. Am J ClinNutr2005;81:1313-1321.
49. WHO 2003; Diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation, Geneva, 28 Jan.-1 Feb 2002. (WHO technical report series; 916)
50. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787